(Q41162237)

English

Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis

scientific article published on April 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

0 references

author name string

Christensen RD

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Brown MS

2

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Hall DC

3

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Lassiter HA

4

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Hill HR

5

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

language of work or name

0 references

publication date

1 April 1991

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

4 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

606-614

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

The Effect of Hybridoma Antibody Administration upon Neutrophil Kinetics during Experimental Type III Group B Streptococcal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Protective Efficacy of Hybridoma Type-Specific Antibody Against Experimental Infection with Group-B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

The effect of administration of immunoglobulin to newborn rats with Escherichia coli sepsis and meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Circulating and storage neutrophils in septic neonatal rats treated with immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Development of immunoglobulin preparations for intravenous use

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Intravenous immunoglobulins as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

The neonatal blood count in health and disease.I. Reference values for neutrophilic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

The leukocyte left shift in clinical and experimental neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Phagocytosis of bacteria by human leukocytes measured by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. III. Interruption of Mother-to-Infant Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Influence of Preimmunization Antibody Levels on the Specificity of the Immune Response to Related Polysaccharide Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Intravenous immune globulin use in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(05)83389-X

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41162237&oldid=1916362707"